Bone grafting is a surgical operation that uses bone grafts or substitutes to reconstruct a misplaced bone in order to treat bone fractures that pose a serious health risk to the patient. Compound fractures are treated with bone grafting, which is commonly employed in spinal fusion procedures.
Bone grafts can be used to treat spinal fractures, anchor a repaired spinal deformity, and prevent mobility between two or more vertebral bodies. The bone graft does not immediately fuse or mend the spine, but it does provide a scaffold or foundation for the patient's body to create new bone.
Bone graft and substitute manufacturers are focused on innovative techniques such as fast prototyping and 3D printing, which are also assisting in the manufacturing of free-form biomaterial scaffolds for tissue regeneration.
Growing prevalence of musculoskeletal disorders, advancements in biocompatible synthetic bone grafts, and increase in demand for dental bone grafts are all driving the global bone grafts and substitutes market forward.
The bone grafts and substitutes market in China is growing due to an increase in the usage of allografts and other alternative products, a steady supply of orthopedic equipment, and a growing acceptance of autograft bone.
Owing to the increasing number of patients who rely on medical settings for crucial orthopedic treatments such as spinal fusion, regenerative therapies, and joint reconstruction surgeries, hospitals are expected to be the most dominating section of the global market during the projection period.
Competitive Landscape
Manufacturers of bone grafts and substitutes are constantly investing in the development of new products with improved bioactivity, biocompatibility, and mechanical qualities. Companies have a varied product portfolio that is technologically advanced, as well as a larger global presence. Key players are constantly launching innovative products in various orthopedic application areas.
For instance,
· The chronOS Strip bone graft substitute is made by Synthes, Inc., a Johnson & Johnson company. The chronOS-tricalcium phosphate granules in this synthetic bone transplant can be perfused with the patient's bone marrow and blood.
Key Takeaways from Market Study
- Global bone grafts and substitutes market to reach a valuation of US$ 4.44 Bn by 2028.
- Market in North America holds a high share of 53.1%.
- Demand for allografts are expected to increase at a significant CAGR over the coming years.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Website https://www.factmr.com/
Tel: +1 (628) 251-1583
